AAK1 and bacterial infectious disease with sepsis: Taken together, our study for the first time discovered a novel 1-hydroxy phenothiazinium-based molecule (PHZ-OH), capable of preventing bacterial sepsis by selectively inhibiting AAK1-mediated LPS internalization for caspase-11 activation, which may provide a novel target and a potent therapeutic molecule in the treatment of bacterial sepsis.